Boston Scientific (BSX) Stock Statistics & Valuation Metrics

Boston Scientific has a market cap or net worth of CHF53.26B. The enterprise value is $76.32B.

Boston Scientific has ― shares outstanding. The number of shares has decreased by -2.65% in one year.

Boston Scientific’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 8.78%.

The current PE Ratio of Boston Scientific is 18.4. Boston Scientific’s PEG ratio is 0.88.

In the last 12 months, Boston Scientific had revenue of 20.07B and earned 2.89B in profits. Earnings per share was 1.96.

In the last 12 months, operating cash flow was 4.34B and capital expenditures -899.00M, giving a free cash flow of 3.44B billion.

Boston Scientific pays an annual dividend of ―, resulting in a dividend yield of ―

Boston Scientific upcoming earnings date is Jul 29, 2026, Before Open (Confirmed).

Boston Scientific as a current ratio of 1.62, with Debt / Equity ratio of 42.64%

In the past 12 months, Boston Scientific has paid 493.00M in taxes.

Boston Scientific EV to EBITDA ratio is 29.70, with an EV/FCF ratio of 41.42.

Boston Scientific has CHF1.52B in cash and marketable securities with CHF11.03B in debt, giving a net cash position of -CHF9.51B billion.

Gross margin is 70.41%, with operating margin of 19.78%, and net profit margin of 14.38%.

The average price target for Boston Scientific is CHF60.37, which is 11.43% higher than the current price. The consensus rating is Strong Buy